These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 15249981
21. Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging. Zhang Z, Mascheri N, Dharmakumar R, Fan Z, Paunesku T, Woloschak G, Li D. Cytotherapy; 2009; 11(1):43-51. PubMed ID: 18956269 [Abstract] [Full Text] [Related]
22. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics. Lutz AM, Weishaupt D, Persohn E, Goepfert K, Froehlich J, Sasse B, Gottschalk J, Marincek B, Kaim AH. Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219 [Abstract] [Full Text] [Related]
23. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. Lind K, Kresse M, Debus NP, Müller RH. J Drug Target; 2002 May; 10(3):221-30. PubMed ID: 12075823 [Abstract] [Full Text] [Related]
24. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JW. Radiology; 2003 Aug; 228(2):480-7. PubMed ID: 12819345 [Abstract] [Full Text] [Related]
25. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging. Lutz AM, Seemayer C, Corot C, Gay RE, Goepfert K, Michel BA, Marincek B, Gay S, Weishaupt D. Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767 [Abstract] [Full Text] [Related]
26. Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs. Kroft LJ, Doornbos J, van der Geest RJ, van der Laarse A, van der Meulen H, de Roos A. Magn Reson Imaging; 1998 Sep; 16(7):755-63. PubMed ID: 9811141 [Abstract] [Full Text] [Related]
27. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, Frenzel T, Lawaczeck R, Wolf KJ, Lange L. J Magn Reson Imaging; 1994 Sep; 4(5):659-68. PubMed ID: 7981510 [Abstract] [Full Text] [Related]
28. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE. Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684 [Abstract] [Full Text] [Related]
29. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters. Tanimoto A, Mukai M, Kuribayashi S. Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765 [Abstract] [Full Text] [Related]
30. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N. Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487 [Abstract] [Full Text] [Related]
31. Recent advances in iron oxide nanocrystal technology for medical imaging. Corot C, Robert P, Idée JM, Port M. Adv Drug Deliv Rev; 2006 Dec 01; 58(14):1471-504. PubMed ID: 17116343 [Abstract] [Full Text] [Related]
33. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases. Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J. Invest Radiol; 2008 Jul 01; 43(7):496-503. PubMed ID: 18580332 [Abstract] [Full Text] [Related]
34. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, Frank JA. Mol Imaging; 2004 Jan 01; 3(1):24-32. PubMed ID: 15142409 [Abstract] [Full Text] [Related]
35. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Desestret V, Brisset JC, Moucharrafie S, Devillard E, Nataf S, Honnorat J, Nighoghossian N, Berthezène Y, Wiart M. Stroke; 2009 May 01; 40(5):1834-41. PubMed ID: 19286601 [Abstract] [Full Text] [Related]
36. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Bos C, Delmas Y, Desmoulière A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N. Radiology; 2004 Dec 01; 233(3):781-9. PubMed ID: 15486216 [Abstract] [Full Text] [Related]
37. MRI detection of macrophages labeled using micrometer-sized iron oxide particles. Williams JB, Ye Q, Hitchens TK, Kaufman CL, Ho C. J Magn Reson Imaging; 2007 Jun 01; 25(6):1210-8. PubMed ID: 17520727 [Abstract] [Full Text] [Related]
38. In vivo detection of developing vessel occlusion in photothrombotic ischemic brain lesions in the rat by iron particle enhanced MRI. Kleinschnitz C, Schütz A, Nölte I, Horn T, Frank M, Solymosi L, Stoll G, Bendszus M. J Cereb Blood Flow Metab; 2005 Nov 01; 25(11):1548-55. PubMed ID: 15917747 [Abstract] [Full Text] [Related]
39. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells]. Zhang GX, Li YJ, Zhang F, Zhao JL, Li KA, Hu YS. Zhonghua Yi Xue Za Zhi; 2007 Jan 23; 87(4):228-32. PubMed ID: 17425864 [Abstract] [Full Text] [Related]